The valuations of some US companies still in ‘start-up mode’ is amazing.
https://www.forbes.com/sites/elanag...osing-200-million-funding-round/#a1ad238345ee
HMS could have chosen any number of US companies to invest and partner with but selected MedAdvisor.
Management have stated there’s many other opportunities with HMS beyond the initial Eliza launch later this year.
Once there’s actual revenue coming in, the share price should open up a bit up, else it’s all just ‘forecasted’, ‘pending’, ‘scheduled’. Unfortunately all these terms are recognised as zero on a balance sheet.
Add to My Watchlist
What is My Watchlist?
